Advanced company searchLink opens in new window

GENEFORM TECHNOLOGIES LIMITED

Company number 04549240

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
27 Dec 2018 PSC07 Cessation of Orion Pharma Uk Limited as a person with significant control on 26 March 2018
24 Dec 2018 PSC07 Cessation of A Person with Significant Control as a person with significant control on 26 March 2018
22 Dec 2018 DISS40 Compulsory strike-off action has been discontinued
21 Dec 2018 CS01 Confirmation statement made on 1 October 2018 with updates
18 Dec 2018 GAZ1 First Gazette notice for compulsory strike-off
03 Aug 2018 AA Audited abridged accounts made up to 26 September 2017
25 Jun 2018 AA01 Previous accounting period shortened from 27 September 2017 to 26 September 2017
10 May 2018 TM01 Termination of appointment of Mikko Tapani Kemppainen as a director on 30 April 2018
10 May 2018 AP01 Appointment of Pekka Juhani Malinen as a director on 30 April 2018
17 Mar 2018 DISS40 Compulsory strike-off action has been discontinued
15 Mar 2018 AA Accounts for a small company made up to 30 September 2016
27 Feb 2018 GAZ1 First Gazette notice for compulsory strike-off
12 Jan 2018 TM01 Termination of appointment of Marko Juhani Tapio Seppanen as a director on 2 November 2015
21 Dec 2017 AA01 Previous accounting period shortened from 28 September 2017 to 27 September 2017
07 Nov 2017 CS01 Confirmation statement made on 1 October 2017 with no updates
28 Sep 2017 AA01 Current accounting period shortened from 29 September 2016 to 28 September 2016
29 Jun 2017 AA01 Previous accounting period shortened from 30 September 2016 to 29 September 2016
13 Dec 2016 CS01 Confirmation statement made on 1 October 2016 with updates
03 Oct 2016 AD01 Registered office address changed from C/O Orion Pharma (Uk) Limited 5 Fleet Place London England EC4M 7rd to C/O Orion Pharma (Uk) Limited 5 Fleet Place London EC4M 7rd on 3 October 2016
04 Jul 2016 AA Full accounts made up to 30 September 2015
02 Jan 2016 DISS40 Compulsory strike-off action has been discontinued
30 Dec 2015 AR01 Annual return made up to 1 October 2015 with full list of shareholders
Statement of capital on 2015-12-30
  • GBP 13,330
29 Dec 2015 GAZ1 First Gazette notice for compulsory strike-off
06 Nov 2015 AP01 Appointment of Mrs Kaisa Tarkkanen as a director on 1 October 2015
06 Nov 2015 TM01 Termination of appointment of Jaakko Sakari Rissanen as a director on 1 October 2015